カテゴリー： 世界, 医療/バイオ, LP Information

世界のアビラテロン市場予測 2023年-2029年

【英語タイトル】Global Abiraterone Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03815）・商品コード：LP23DC03815
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：97
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアビラテロン市場」は、過去の販売実績から2022年の世界のアビラテロンの総販売量を検討し、2023年から2029年の予測されるアビラテロンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアビラテロンの市場規模を掲載し、XXX百万米ドル規模の世界のアビラテロン市場の詳細な分析を提供します。本インサイトレポートは、世界のアビラテロン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアビラテロン市場における各社の独自のポジションをより深く理解するために、アビラテロン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアビラテロン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アビラテロンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アビラテロンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アビラテロンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アビラテロンの世界主要メーカーとしては、Sterling、 MSN、 Dr. Reddy's Laboratories、 Industriale Chimica、 Anant Labs、 Aurisco Pharma、 Hubei Biocause、 Shandong Joyochem、 Midas Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアビラテロン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアビラテロン市場をセグメンテーションし、種類別 (純度≧98%、純度≧99%)、用途別 (錠剤、カプセル)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≧98%、純度≧99%

・用途別区分：錠剤、カプセル

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアビラテロン市場の10年間の市場状況・展望は？
・世界および地域別に見たアビラテロン市場成長の要因は何か？
・アビラテロンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・アビラテロンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アビラテロンの年間販売量2018-2029、地域別現状・将来分析
・アビラテロンの種類別セグメント：純度≧98%、純度≧99%
・アビラテロンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アビラテロンの用途別セグメント：錠剤、カプセル
・アビラテロンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアビラテロン市場
・企業別のグローバルアビラテロン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアビラテロンの年間売上：2018-2023年の売上、市場シェア
・企業別のアビラテロン販売価格
・主要企業のアビラテロン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アビラテロンの地域別レビュー
・地域別のアビラテロン市場規模2018-2023：年間販売量、売上
・主要国別のアビラテロン市場規模2018-2023：年間販売量、売上
・南北アメリカのアビラテロン販売の成長
・アジア太平洋のアビラテロン販売の成長
・ヨーロッパのアビラテロン販売の成長
・中東・アフリカのアビラテロン販売の成長

南北アメリカ市場
・南北アメリカの国別のアビラテロン販売量、売上（2018-2023）
・南北アメリカのアビラテロンの種類別販売量
・南北アメリカのアビラテロンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアビラテロン販売量、売上（2018-2023）
・アジア太平洋のアビラテロンの種類別販売量
・アジア太平洋のアビラテロンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアビラテロン販売量、売上（2018-2023）
・ヨーロッパのアビラテロンの種類別販売量
・ヨーロッパのアビラテロンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアビラテロン販売量、売上（2018-2023）
・中東・アフリカのアビラテロンの種類別販売量
・中東・アフリカのアビラテロンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アビラテロンの製造コスト構造分析
・アビラテロンの製造プロセス分析
・アビラテロンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アビラテロンの主要なグローバル販売業者
・アビラテロンの主要なグローバル顧客

地域別のアビラテロン市場予測レビュー
・地域別のアビラテロン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アビラテロンの種類別市場規模予測
・アビラテロンの用途別市場規模予測

主要企業分析
Sterling、 MSN、 Dr. Reddy's Laboratories、 Industriale Chimica、 Anant Labs、 Aurisco Pharma、 Hubei Biocause、 Shandong Joyochem、 Midas Pharma
・企業情報
・アビラテロン製品
・アビラテロン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Abiraterone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Abiraterone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Abiraterone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Abiraterone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Abiraterone players cover Sterling, MSN, Dr. Reddy’s Laboratories, Industriale Chimica, Anant Labs, Aurisco Pharma, Hubei Biocause, Shandong Joyochem and Midas Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Abiraterone Industry Forecast” looks at past sales and reviews total world Abiraterone sales in 2022, providing a comprehensive analysis by region and market sector of projected Abiraterone sales for 2023 through 2029. With Abiraterone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Abiraterone industry.
This Insight Report provides a comprehensive analysis of the global Abiraterone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Abiraterone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Abiraterone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Abiraterone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Abiraterone.
This report presents a comprehensive overview, market shares, and growth opportunities of Abiraterone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Tablets
Capsules
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Sterling
MSN
Dr. Reddy’s Laboratories
Industriale Chimica
Anant Labs
Aurisco Pharma
Hubei Biocause
Shandong Joyochem
Midas Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Abiraterone market?
What factors are driving Abiraterone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Abiraterone market opportunities vary by end market size?
How does Abiraterone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Abiraterone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Abiraterone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Abiraterone by Country/Region, 2018, 2022 & 2029
2.2 Abiraterone Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 Abiraterone Sales by Type
2.3.1 Global Abiraterone Sales Market Share by Type (2018-2023)
2.3.2 Global Abiraterone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Abiraterone Sale Price by Type (2018-2023)
2.4 Abiraterone Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.5 Abiraterone Sales by Application
2.5.1 Global Abiraterone Sale Market Share by Application (2018-2023)
2.5.2 Global Abiraterone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Abiraterone Sale Price by Application (2018-2023)
3 Global Abiraterone by Company
3.1 Global Abiraterone Breakdown Data by Company
3.1.1 Global Abiraterone Annual Sales by Company (2018-2023)
3.1.2 Global Abiraterone Sales Market Share by Company (2018-2023)
3.2 Global Abiraterone Annual Revenue by Company (2018-2023)
3.2.1 Global Abiraterone Revenue by Company (2018-2023)
3.2.2 Global Abiraterone Revenue Market Share by Company (2018-2023)
3.3 Global Abiraterone Sale Price by Company
3.4 Key Manufacturers Abiraterone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Abiraterone Product Location Distribution
3.4.2 Players Abiraterone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Abiraterone by Geographic Region
4.1 World Historic Abiraterone Market Size by Geographic Region (2018-2023)
4.1.1 Global Abiraterone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Abiraterone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Abiraterone Market Size by Country/Region (2018-2023)
4.2.1 Global Abiraterone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Abiraterone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Abiraterone Sales Growth
4.4 APAC Abiraterone Sales Growth
4.5 Europe Abiraterone Sales Growth
4.6 Middle East & Africa Abiraterone Sales Growth
5 Americas
5.1 Americas Abiraterone Sales by Country
5.1.1 Americas Abiraterone Sales by Country (2018-2023)
5.1.2 Americas Abiraterone Revenue by Country (2018-2023)
5.2 Americas Abiraterone Sales by Type
5.3 Americas Abiraterone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Abiraterone Sales by Region
6.1.1 APAC Abiraterone Sales by Region (2018-2023)
6.1.2 APAC Abiraterone Revenue by Region (2018-2023)
6.2 APAC Abiraterone Sales by Type
6.3 APAC Abiraterone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Abiraterone by Country
7.1.1 Europe Abiraterone Sales by Country (2018-2023)
7.1.2 Europe Abiraterone Revenue by Country (2018-2023)
7.2 Europe Abiraterone Sales by Type
7.3 Europe Abiraterone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Abiraterone by Country
8.1.1 Middle East & Africa Abiraterone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Abiraterone Revenue by Country (2018-2023)
8.2 Middle East & Africa Abiraterone Sales by Type
8.3 Middle East & Africa Abiraterone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Abiraterone
10.3 Manufacturing Process Analysis of Abiraterone
10.4 Industry Chain Structure of Abiraterone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Abiraterone Distributors
11.3 Abiraterone Customer
12 World Forecast Review for Abiraterone by Geographic Region
12.1 Global Abiraterone Market Size Forecast by Region
12.1.1 Global Abiraterone Forecast by Region (2024-2029)
12.1.2 Global Abiraterone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Abiraterone Forecast by Type
12.7 Global Abiraterone Forecast by Application
13 Key Players Analysis
13.1 Sterling
13.1.1 Sterling Company Information
13.1.2 Sterling Abiraterone Product Portfolios and Specifications
13.1.3 Sterling Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sterling Main Business Overview
13.1.5 Sterling Latest Developments
13.2 MSN
13.2.1 MSN Company Information
13.2.2 MSN Abiraterone Product Portfolios and Specifications
13.2.3 MSN Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 MSN Main Business Overview
13.2.5 MSN Latest Developments
13.3 Dr. Reddy’s Laboratories
13.3.1 Dr. Reddy’s Laboratories Company Information
13.3.2 Dr. Reddy’s Laboratories Abiraterone Product Portfolios and Specifications
13.3.3 Dr. Reddy’s Laboratories Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dr. Reddy’s Laboratories Main Business Overview
13.3.5 Dr. Reddy’s Laboratories Latest Developments
13.4 Industriale Chimica
13.4.1 Industriale Chimica Company Information
13.4.2 Industriale Chimica Abiraterone Product Portfolios and Specifications
13.4.3 Industriale Chimica Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Industriale Chimica Main Business Overview
13.4.5 Industriale Chimica Latest Developments
13.5 Anant Labs
13.5.1 Anant Labs Company Information
13.5.2 Anant Labs Abiraterone Product Portfolios and Specifications
13.5.3 Anant Labs Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Anant Labs Main Business Overview
13.5.5 Anant Labs Latest Developments
13.6 Aurisco Pharma
13.6.1 Aurisco Pharma Company Information
13.6.2 Aurisco Pharma Abiraterone Product Portfolios and Specifications
13.6.3 Aurisco Pharma Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurisco Pharma Main Business Overview
13.6.5 Aurisco Pharma Latest Developments
13.7 Hubei Biocause
13.7.1 Hubei Biocause Company Information
13.7.2 Hubei Biocause Abiraterone Product Portfolios and Specifications
13.7.3 Hubei Biocause Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hubei Biocause Main Business Overview
13.7.5 Hubei Biocause Latest Developments
13.8 Shandong Joyochem
13.8.1 Shandong Joyochem Company Information
13.8.2 Shandong Joyochem Abiraterone Product Portfolios and Specifications
13.8.3 Shandong Joyochem Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shandong Joyochem Main Business Overview
13.8.5 Shandong Joyochem Latest Developments
13.9 Midas Pharma
13.9.1 Midas Pharma Company Information
13.9.2 Midas Pharma Abiraterone Product Portfolios and Specifications
13.9.3 Midas Pharma Abiraterone Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Midas Pharma Main Business Overview
13.9.5 Midas Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Abiraterone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Abiraterone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Abiraterone Sales by Type (2018-2023) & (K Units)
Table 6. Global Abiraterone Sales Market Share by Type (2018-2023)
Table 7. Global Abiraterone Revenue by Type (2018-2023) & ($ million)
Table 8. Global Abiraterone Revenue Market Share by Type (2018-2023)
Table 9. Global Abiraterone Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Abiraterone Sales by Application (2018-2023) & (K Units)
Table 11. Global Abiraterone Sales Market Share by Application (2018-2023)
Table 12. Global Abiraterone Revenue by Application (2018-2023)
Table 13. Global Abiraterone Revenue Market Share by Application (2018-2023)
Table 14. Global Abiraterone Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Abiraterone Sales by Company (2018-2023) & (K Units)
Table 16. Global Abiraterone Sales Market Share by Company (2018-2023)
Table 17. Global Abiraterone Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Abiraterone Revenue Market Share by Company (2018-2023)
Table 19. Global Abiraterone Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Abiraterone Producing Area Distribution and Sales Area
Table 21. Players Abiraterone Products Offered
Table 22. Abiraterone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Abiraterone Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Abiraterone Sales Market Share Geographic Region (2018-2023)
Table 27. Global Abiraterone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Abiraterone Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Abiraterone Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Abiraterone Sales Market Share by Country/Region (2018-2023)
Table 31. Global Abiraterone Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Abiraterone Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Abiraterone Sales by Country (2018-2023) & (K Units)
Table 34. Americas Abiraterone Sales Market Share by Country (2018-2023)
Table 35. Americas Abiraterone Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Abiraterone Revenue Market Share by Country (2018-2023)
Table 37. Americas Abiraterone Sales by Type (2018-2023) & (K Units)
Table 38. Americas Abiraterone Sales by Application (2018-2023) & (K Units)
Table 39. APAC Abiraterone Sales by Region (2018-2023) & (K Units)
Table 40. APAC Abiraterone Sales Market Share by Region (2018-2023)
Table 41. APAC Abiraterone Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Abiraterone Revenue Market Share by Region (2018-2023)
Table 43. APAC Abiraterone Sales by Type (2018-2023) & (K Units)
Table 44. APAC Abiraterone Sales by Application (2018-2023) & (K Units)
Table 45. Europe Abiraterone Sales by Country (2018-2023) & (K Units)
Table 46. Europe Abiraterone Sales Market Share by Country (2018-2023)
Table 47. Europe Abiraterone Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Abiraterone Revenue Market Share by Country (2018-2023)
Table 49. Europe Abiraterone Sales by Type (2018-2023) & (K Units)
Table 50. Europe Abiraterone Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Abiraterone Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Abiraterone Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Abiraterone Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Abiraterone Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Abiraterone Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Abiraterone Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Abiraterone
Table 58. Key Market Challenges & Risks of Abiraterone
Table 59. Key Industry Trends of Abiraterone
Table 60. Abiraterone Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Abiraterone Distributors List
Table 63. Abiraterone Customer List
Table 64. Global Abiraterone Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Abiraterone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Abiraterone Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Abiraterone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Abiraterone Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Abiraterone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Abiraterone Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Abiraterone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Abiraterone Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Abiraterone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Abiraterone Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Abiraterone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Abiraterone Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Abiraterone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sterling Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 79. Sterling Abiraterone Product Portfolios and Specifications
Table 80. Sterling Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sterling Main Business
Table 82. Sterling Latest Developments
Table 83. MSN Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 84. MSN Abiraterone Product Portfolios and Specifications
Table 85. MSN Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. MSN Main Business
Table 87. MSN Latest Developments
Table 88. Dr. Reddy's Laboratories Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 89. Dr. Reddy's Laboratories Abiraterone Product Portfolios and Specifications
Table 90. Dr. Reddy's Laboratories Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Dr. Reddy's Laboratories Main Business
Table 92. Dr. Reddy's Laboratories Latest Developments
Table 93. Industriale Chimica Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 94. Industriale Chimica Abiraterone Product Portfolios and Specifications
Table 95. Industriale Chimica Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Industriale Chimica Main Business
Table 97. Industriale Chimica Latest Developments
Table 98. Anant Labs Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 99. Anant Labs Abiraterone Product Portfolios and Specifications
Table 100. Anant Labs Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Anant Labs Main Business
Table 102. Anant Labs Latest Developments
Table 103. Aurisco Pharma Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurisco Pharma Abiraterone Product Portfolios and Specifications
Table 105. Aurisco Pharma Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Aurisco Pharma Main Business
Table 107. Aurisco Pharma Latest Developments
Table 108. Hubei Biocause Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 109. Hubei Biocause Abiraterone Product Portfolios and Specifications
Table 110. Hubei Biocause Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Hubei Biocause Main Business
Table 112. Hubei Biocause Latest Developments
Table 113. Shandong Joyochem Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 114. Shandong Joyochem Abiraterone Product Portfolios and Specifications
Table 115. Shandong Joyochem Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Shandong Joyochem Main Business
Table 117. Shandong Joyochem Latest Developments
Table 118. Midas Pharma Basic Information, Abiraterone Manufacturing Base, Sales Area and Its Competitors
Table 119. Midas Pharma Abiraterone Product Portfolios and Specifications
Table 120. Midas Pharma Abiraterone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Midas Pharma Main Business
Table 122. Midas Pharma Latest Developments
List of Figures
Figure 1. Picture of Abiraterone
Figure 2. Abiraterone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Abiraterone Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Abiraterone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Abiraterone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global Abiraterone Sales Market Share by Type in 2022
Figure 12. Global Abiraterone Revenue Market Share by Type (2018-2023)
Figure 13. Abiraterone Consumed in Tablets
Figure 14. Global Abiraterone Market: Tablets (2018-2023) & (K Units)
Figure 15. Abiraterone Consumed in Capsules
Figure 16. Global Abiraterone Market: Capsules (2018-2023) & (K Units)
Figure 17. Global Abiraterone Sales Market Share by Application (2022)
Figure 18. Global Abiraterone Revenue Market Share by Application in 2022
Figure 19. Abiraterone Sales Market by Company in 2022 (K Units)
Figure 20. Global Abiraterone Sales Market Share by Company in 2022
Figure 21. Abiraterone Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Abiraterone Revenue Market Share by Company in 2022
Figure 23. Global Abiraterone Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Abiraterone Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Abiraterone Sales 2018-2023 (K Units)
Figure 26. Americas Abiraterone Revenue 2018-2023 ($ Millions)
Figure 27. APAC Abiraterone Sales 2018-2023 (K Units)
Figure 28. APAC Abiraterone Revenue 2018-2023 ($ Millions)
Figure 29. Europe Abiraterone Sales 2018-2023 (K Units)
Figure 30. Europe Abiraterone Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Abiraterone Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Abiraterone Revenue 2018-2023 ($ Millions)
Figure 33. Americas Abiraterone Sales Market Share by Country in 2022
Figure 34. Americas Abiraterone Revenue Market Share by Country in 2022
Figure 35. Americas Abiraterone Sales Market Share by Type (2018-2023)
Figure 36. Americas Abiraterone Sales Market Share by Application (2018-2023)
Figure 37. United States Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Abiraterone Sales Market Share by Region in 2022
Figure 42. APAC Abiraterone Revenue Market Share by Regions in 2022
Figure 43. APAC Abiraterone Sales Market Share by Type (2018-2023)
Figure 44. APAC Abiraterone Sales Market Share by Application (2018-2023)
Figure 45. China Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Abiraterone Sales Market Share by Country in 2022
Figure 53. Europe Abiraterone Revenue Market Share by Country in 2022
Figure 54. Europe Abiraterone Sales Market Share by Type (2018-2023)
Figure 55. Europe Abiraterone Sales Market Share by Application (2018-2023)
Figure 56. Germany Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Abiraterone Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Abiraterone Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Abiraterone Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Abiraterone Sales Market Share by Application (2018-2023)
Figure 65. Egypt Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Abiraterone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Abiraterone in 2022
Figure 71. Manufacturing Process Analysis of Abiraterone
Figure 72. Industry Chain Structure of Abiraterone
Figure 73. Channels of Distribution
Figure 74. Global Abiraterone Sales Market Forecast by Region (2024-2029)
Figure 75. Global Abiraterone Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Abiraterone Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Abiraterone Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Abiraterone Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Abiraterone Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアビラテロン市場予測 2023年-2029年] (コード：LP23DC03815)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアビラテロン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品用アビラテロン酢酸塩市場予測 2023年-2029年
  • 世界の製薬用ガラスチューブ市場予測 2023年-2029年
  • 世界のアルテスネイト注射市場予測 2023年-2029年
  • 世界の医薬品用硫酸カルシウム市場予測 2023年-2029年
  • 世界の医薬品用酢酸コハク酸ヒプロメロース市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆